The US Food and Drug Administration (FDA) has recommended voluntary recall of certain extended-release (ER) versions of metformin because testing has revealed excessive levels of ...
Two pharmaceutical companies recently issued voluntary recalls for extended-release versions of the diabetes drug metformin, because it may contain high levels of a cancer-causing chemical, according ...
Apotex has recalled all its Metformin Hydrochloride Extended-Release Tablets 500 mg in the United States for too much of carcinogen NDMA, the same “impurity” that got all the Zantac yanked earlier ...
Apotex Corp is voluntarily recalling all lots of Metformin Hydrochloride Extended-Release Tablets, USP 500mg within expiry to retail level. Apotex was notified by the U.S. Food and Drug Administration ...
Nostrum Laboratories has voluntarily recalled another lot of metformin HCl extended-release tablets 750 mg dosage, expanding their initial announcement in November 2020. According to the new notice, ...
Pharma Major Lupin Limited (Lupin) announced today that its US subsidiary, Lupin Pharmaceuticals Inc., has launched its Metformin HCl ER Tablets, 500 mg and 1000 mg to market a generic equivalent of ...
Please provide your email address to receive an email when new articles are posted on . Nostrum Laboratories, Inc., is voluntarily recalling two lots of metformin hydrochloride extended-release ...
Two pharmaceutical companies recently issued voluntary recalls for extended-release versions of the diabetes drug metformin, because it may contain high levels of a cancer-causing chemical, according ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback